Abstract Presentation

QRL-201-01 - A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED MULTIPLEASCENDING DOSE STUDY TO EVALUATE THE SAFETY AND TOLERABILITY OF QRL201 IN AMYOTROPHIC LATERAL SCLEROSIS